1. Home
  2. MNOV vs PETS Comparison

MNOV vs PETS Comparison

Compare MNOV & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • PETS
  • Stock Information
  • Founded
  • MNOV 2000
  • PETS 1996
  • Country
  • MNOV United States
  • PETS United States
  • Employees
  • MNOV N/A
  • PETS N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • PETS Retail-Drug Stores and Proprietary Stores
  • Sector
  • MNOV Health Care
  • PETS Consumer Staples
  • Exchange
  • MNOV Nasdaq
  • PETS Nasdaq
  • Market Cap
  • MNOV 87.3M
  • PETS 98.6M
  • IPO Year
  • MNOV 2005
  • PETS N/A
  • Fundamental
  • Price
  • MNOV $1.83
  • PETS $5.11
  • Analyst Decision
  • MNOV Strong Buy
  • PETS Sell
  • Analyst Count
  • MNOV 1
  • PETS 2
  • Target Price
  • MNOV $9.00
  • PETS $3.50
  • AVG Volume (30 Days)
  • MNOV 37.0K
  • PETS 249.5K
  • Earning Date
  • MNOV 02-13-2025
  • PETS 02-06-2025
  • Dividend Yield
  • MNOV N/A
  • PETS N/A
  • EPS Growth
  • MNOV N/A
  • PETS N/A
  • EPS
  • MNOV N/A
  • PETS N/A
  • Revenue
  • MNOV N/A
  • PETS $259,343,000.00
  • Revenue This Year
  • MNOV N/A
  • PETS N/A
  • Revenue Next Year
  • MNOV N/A
  • PETS $3.36
  • P/E Ratio
  • MNOV N/A
  • PETS N/A
  • Revenue Growth
  • MNOV N/A
  • PETS N/A
  • 52 Week Low
  • MNOV $1.12
  • PETS $2.90
  • 52 Week High
  • MNOV $2.55
  • PETS $7.24
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 35.00
  • PETS 52.60
  • Support Level
  • MNOV $1.90
  • PETS $4.74
  • Resistance Level
  • MNOV $2.20
  • PETS $5.30
  • Average True Range (ATR)
  • MNOV 0.08
  • PETS 0.24
  • MACD
  • MNOV -0.03
  • PETS 0.02
  • Stochastic Oscillator
  • MNOV 0.00
  • PETS 65.06

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Share on Social Networks: